The SARS-CoV-2 501Y.V2 lineage has been recently been shown to predominate in the Eastern Cape, Western Cape and KwaZulu-Natal provinces of South Africa, all of which experienced major outbreaks of COVID-19. This variant of concern harbours mutations associated with increased transmissibility and neutralizing antibody resistance. In this report, we describe a preliminary analysis of 479 sequences from Gauteng, the country’s economic hub, indicating that the 501Y.V2 lineage first appeared in November and by December accounted for 84% (62/74) of sequences. The Eastern Cape, Western Cape, KwaZulu-Natal and Gauteng data suggests that 501Y.V2 lineage may be predominant throughout South Africa.

Doxycycline Now More Accessible for Malaria Chemoprevention
Doxycycline has been officially recognised as an important tool for malaria chemoprevention in South